Biomea Fusion, Inc.
BMEA
$1.42
$0.042.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/23/2025
-
SeekingAlpha
10/23/2025
-
Seeking Alpha: Transcripts
10/22/2025
-
GuruFocus
10/21/2025
-
Globe Newswire
10/16/2025
-
MarketBeat
10/13/2025
-
MarketBeat
10/10/2025
-
Simply Wall St
10/9/2025
-
MarketBeat
10/8/2025
-
Simply Wall St
10/7/2025
-
SeekingAlpha
10/7/2025
-
Seeking Alpha: Transcripts
10/7/2025
-
SeekingAlpha
10/7/2025
-
MarketBeat
10/7/2025
-
Benzinga
10/7/2025
-
SeekingAlpha
10/7/2025
-
GuruFocus
10/7/2025
-
Seeking Alpha - Healthcare
10/7/2025
-
The Fly
10/7/2025
-
GuruFocus
10/7/2025
-
Globe Newswire
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
10/6/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, August 5, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 980 9099
Address
1599 Industrial Road
San Carlos, CA 94070
San Carlos, CA 94070
Country
Year Founded
Business Description
Sector
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic...
more